Vikas Lifecare

2.60
+0.02
(0.78%)
Market Cap
482.99 Cr
EPS
-0.04
PE Ratio
222.00
Dividend Yield
0.00 %
52 Week High
5.64
52 Week Low
2.28
PB Ratio
0.90
Debt to Equity
0.08
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
310.10
#1 24,242.83
21.82
#1 99,333.60
12.69
#1 1,813
183.33
59.28
76.80
12,276.45
166.25
548.76
-23.08
70
43.00
78.16
70.90
10,635.00
108.02
2.69
-94.36
87
-96.85
51.39
551.80
3,884.67
19.23
310.96
9.35
406
55.67
51.90
133.00
2,374.77
89.80
250.42
-48.78
27
120.35
46.45
226.55
2,215.06
113.17
299.41
#1 8,85,900.00
20
#1 2,244.44
78.17
565.00
2,015.48
48.39
83.22
6,408.33
41
256.25
56.30
59.09
1,983.93
487.22
80.42
-9.60
3
-57.14
42.86
138.74
1,765.93
44.41
308.52
108.37
40
262.79
76.61
41,801.10
1,284.80
#1 11.16
64.82
15.93
115
-27.43
68.15

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
5.29 %
Net Income Growth
-187.10 %
Cash Flow Change
62.79 %
ROE
-160.43 %
ROCE
-172.76 %
EBITDA Margin (Avg.)
-279.94 %

Quarterly Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
5
33
13
33
25
72
114
134
94
133
135
86
111
123
102
136
94
138
117
156
Expenses
4
30
12
34
23
68
110
100
91
127
129
117
96
114
104
134
92
136
121
158
EBITDA
1
3
1
-0
2
4
4
33
4
6
5
-31
14
9
-2
2
2
2
-4
-2
Operating Profit %
-5 %
5 %
-27 %
-12 %
3 %
-1 %
-3 %
2 %
1 %
3 %
3 %
1 %
3 %
2 %
-5 %
-2 %
-0 %
-1 %
-3 %
-17 %
Depreciation
0
0
0
0
0
0
0
1
1
0
1
1
1
1
1
1
1
2
2
2
Interest
1
2
1
2
1
0
0
0
0
0
1
1
1
1
1
1
1
1
1
2
Profit Before Tax
0
0
0
-2
0
3
4
32
3
5
4
-32
13
8
-3
-1
0
-1
-7
-5
Tax
0
0
0
2
0
1
1
9
-0
3
-3
-6
1
0
1
1
3
-3
0
-2
Net Profit
0
0
0
-4
0
3
3
23
3
3
6
-27
12
8
-4
-2
-3
2
-7
-3
EPS in ₹
0.00
0.01
-0.21
-0.06
0.00
0.03
0.06
0.21
0.23
0.02
0.04
-0.20
0.08
0.06
-0.03
-0.03
-0.02
0.01
-0.04
-0.02

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
149
321
455
555
729
Fixed Assets
12
28
47
56
51
Current Assets
122
122
227
239
270
Capital Work in Progress
0
0
0
0
1
Investments
3
84
77
183
5
Other Assets
133
208
331
316
0
Total Liabilities
149
321
455
555
729
Current Liabilities
66
105
106
53
153
Non Current Liabilities
16
17
15
23
43
Total Equity
67
200
334
478
532
Reserve & Surplus
0
90
187
291
346
Share Capital
66
110
144
165
186

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
0
8
2
4
Investing Activities
12
-37
-37
-91
Operating Activities
-8
-15
-112
-42
Financing Activities
-4
59
151
137

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 2.72 3.05
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 3.65 3.18
22 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 Oct 2024 4.90 4.44
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 4.69 4.47
01 Nov 2021 RIGHTS Rights
4:21
29 Oct 2021 3.55 3.67
06 May 2021 CHANGE OF NAME Change Of Name
NA
06 May 2021 2.57 2.57

Announcements

Closure of Trading Window5 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Outcome Of Board Meeting Held On Wednesday May 28 2025May 28, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday May 28 2025May 28, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On May 28 2025May 24, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Outcome Of Circular Resolution Passed By Board Of Directors On May 14 2025.May 14, 2025
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulation 2015May 10, 2025
Reporting Of Initial Disclosure To Be Made By Entities Identified As Large CorporatesApr 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceApr 25, 2025
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015Apr 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Closure of Trading WindowMar 29, 2025
Intimation Under Regulation 30 Read With Para B Of Part A Of Schedule III Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing RegulatiFeb 21, 2025
Addendum Of Outcome Of Board Meeting Held On February 14 2025Feb 18, 2025
Disclosure Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Feb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Sub: Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On December 31 2024 As Per Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) ReFeb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2025Feb 14, 2025
Disclosure Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 10, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On February 14 2025Feb 10, 2025
Disclosure Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 20, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Closure of Trading WindowDec 31, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On December 20, 2024Dec 17, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 16, 2024
Disclosure under Regulation 30A of LODRDec 05, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On November 30, 2024Nov 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 23, 2024
Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On September 30, 2024 As Per Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015Oct 22, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On October 22, 2024Oct 22, 2024
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On October 22, 2024Oct 16, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 02, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2024
Closure of Trading WindowSep 30, 2024
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Sep 20, 2024
Reg. 34 (1) Annual Report.Sep 15, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2024
Notice Of 29Th Annual General Meeting Of The Company.Sep 07, 2024
INTIMATION OF BOOK CLOSURE FOR THE PURPOSE OF 29TH ANNUAL GENERAL MEETING.Sep 06, 2024
Board Meeting Outcome for Meeting Held On September 06, 2024.Sep 06, 2024
Intimation Of Withdrawal Of Application Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Sep 04, 2024
Vikas Lifecare Limited Collaborates With DEAL-DRDO, IIT Delhi, And CSIR-NPL For Development Of Nano Composites For EMI Shielding ApplicationsAug 05, 2024
Statement Of Deviation Or Variation In The Use Of Proceeds Of Preferential Issue For The Quarter Ended June 30, 2024Aug 05, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2024
Vikas Lifecare Limited Is Pleased To Share The Updates On The Status Of The Acquisition Process Of Ebix IncJul 27, 2024
Vikas Lifecare Limited Is Pleased To Share The Updates On The Status Of The Acquisition Process Of Ebix Inc., Wherein An Amount Of USD 14 Million (INR 117 Crores Approx) Has Been Remitted By The Consortium On 26Th July 2024;Jul 27, 2024
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015Jul 26, 2024

Technical Indicators

RSI(14)
Neutral
47.35
ATR(14)
Less Volatile
0.09
STOCH(9,6)
Neutral
64.03
STOCH RSI(14)
Neutral
79.02
MACD(12,26)
Bullish
0.01
ADX(14)
Weak Trend
8.38
UO(9)
Bearish
32.92
ROC(12)
Downtrend And Accelerating
-0.77
WillR(14)
Neutral
-44.44